Capitalizing on a gene therapy boom, Avrobio locks in $60M – MedCity News
MedCity News |
Capitalizing on a gene therapy boom, Avrobio locks in $60M
MedCity News Cambridge, Massachusetts-based Avrobio has closed an oversubscribed $60 million Series B financing round to further its ex vivo lentiviral platform for the treatment of lysosomal storage disorders. It’s one more sign that after decades of ups and downs … |
Genetic Literacy Project |
Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine
Genetic Literacy Project Editor’s Note: Novartis CEO Joseph Jimenez retired in January after eight years in the top job at one of the world’s top pharmaceutical companies. During his tenure, the company helped lead a movement that put gene therapies on the map. Scientific … |
